Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 688.4 | 692.8 | 504.2 | 368.7 |
| Revenue growth | -0.6% | 37.4% | 36.8% | |
| Cost of goods sold | 434.8 | 406.0 | 295.9 | 219.9 |
| Gross profit | 253.7 | 286.8 | 208.2 | 148.8 |
| Gross margin | 36.8% | 41.4% | 41.3% | 40.4% |
| Selling, general and administrative | 150.7 | 116.8 | 70.9 | 62.4 |
| Research and development | 29.1 | 28.3 | 23.5 | 20.6 |
| EBITA | 72.3 | 115.2 | 106.3 | 61.5 |
| EBITA margin | 10.5% | 16.6% | 21.1% | 16.7% |
| Amortization of intangibles | 14.7 | 14.0 | 11.1 | 10.5 |
| EBIT | 57.7 | 101.2 | 95.2 | 51.0 |
| EBIT margin | 8.4% | 14.6% | 18.9% | 13.8% |
| Pre-tax income | 78.3 | -16.7 | 41.7 | -4.3 |
| Income taxes | 4.5 | 10.4 | 8.8 | -4.9 |
| Tax rate | 5.7% | | 21.2% | 113.0% |
| Net income | 73.8 | -27.1 | 32.9 | 0.6 |
| Net margin | 10.7% | -3.9% | 6.5% | 0.2% |
| |
| Diluted EPS | $0.63 | ($0.30) | $0.49 | $0.01 |
| Shares outstanding (diluted) | 117.2 | 90.0 | 67.7 | 67.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|